Skip to main content
. 2019 Oct 4;16(10):e1002891. doi: 10.1371/journal.pmed.1002891

Fig 1. Study flow sheet.

Fig 1

AE, adverse event; DOT, directly observed therapy; INH, isoniazid; IS, ingestion sensor; IS-Rifamate, IS-enabled combination isoniazid 150 mg/rifampin 300 mg; PK, pharmacokinetic; SOC, standard of care; TB, tuberculosis; WOT, wirelessly observed therapy.